Blood Gas and Electrolyte Analyzers Market Size By Modality (Bench Top, Portable), By Product (Blood Gas Analyzers, Electrolyte Analyzers, Combined Analyzers, Consumables), By End-use (Central Laboratories, Point-of-Care, Diagnostic Centers) Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026

Industry trends

Blood Gas and Electrolyte Analyzers Market size surpassed USD 3.6 billion in 2019 and is poised to grow at a CAGR of over 6.9% between 2019 to 2026. Blood gas and electrolyte analyzers are used in various parameters such as blood vessel haemorrhage, diabetes, drug overdose and shock for testing including hydrogen ion, electrolytes, and oxygen concentration. Blood gas and electrolyte analyzers provide accurate results for acid-base balance, blood gases, and ionized calcium.
 

Get more details on this report - Request Free Sample PDF
 

Growing prevalence of chronic disorders coupled with technological advancements in blood gas and electrolyte analyzers are major factors for market growth. In addition, rising geriatric population will positively influence the market growth. The geriatric population is mostly prone to hypoxemia, cardiogenic shock, cardiopulmonary resuscitation and cardiac arrhythmias. The management of these life-threatening conditions immensely relies on rapid blood gas analysis thereby upsurge the market demand. Furthermore, increasing adoption of high throughput and integrated systems in central laboratories, as well as point-of-care systems, will help in driving the market size.
 

Request 15% Free Customization on this Report
 

Demographic trends coupled with technological advancement in ophthalmology will offer growth opportunities

Adoption of an unhealthy diet coupled with lifestyle habits including smoking and alcohol consumption are the major factors for the high prevalence of chronic conditions, thus, boosting the blood gas and electrolyte analyzers market growth. Increasing focus of industry players on providing innovative blood gas and electrolyte analyzers and consumables will drive market expansion. Such technology along with a substantial increase in R&D for novel procedures in blood gas and electrolyte analysis will boost market growth in forthcoming years. However, high cost associated with advanced analyzers and stringent regulatory landscape may hamper blood gas and electrolyte analyzers industry growth over the forecast period.
 

Get more details on this report - Request Free Sample PDF
 

Adoption and clinical performance of bench top analyzers will drive the segmental growth

The bench top segment was valued around USD 1.3 Bn in 2019 and is estimated to grow significantly during the forecast period. Adoption of bench top analyzers for arterial blood gas analysis will upsurge segmental growth. Bench top analyzers provide a range of benefits such as individual biosensor technology, broad test menu and low cost of operation. Such benefits will drive in expanding the market growth.
 

Growing elderly population susceptible to chronic diseases will drive the industry growth

Get more details on this report - Request Free Sample PDF
 

The blood gas analyzers market will witness lucrative CAGR of around 5% during the analysis period. The segmental growth is majorly due to increasing number of patients in emergency wards, operation rooms and intensive care. The growing elderly population is more susceptible to various chronic and infectious disorders. This has led to an increase in number of patients in emergency wards receiving critical care. Additionally, industry players are focusing on development of technologically advanced blood gas and blood electrolyte analyzers, thereby driving the market growth.
 

Availability of technologically advanced equipment in hospitals will upsurge the market growth

Diagnostic centers segment held around 9% revenue share in 2019. Factors such as growing number of diagnostic centers, R&D expenditure and new entrants & ventures are contributing to segmental growth. Diagnostic centers are equipped with advanced infrastructure as well as equipment needed in ICU including different types of blood gas and electrolyte analyzers. Furthermore, applications of blood gas and electrolyte analyzers, in the measurement of various elements and disease detection such as sodium, pH, and glucose are anticipated to foster the blood gas and electrolyte analyzers industry growth.
 

Healthcare services access for treatment will augment the business growth in Asia Pacific

Asia Pacific blood gas and electrolyte analyzers market accounted for considerable revenue in 2019 and is poised to exceed USD 1.3 Bn by 2026. Regional growth is attributed to increasing prevalence of chronic diseases such as blood pressure, diabetes and hypertension. Moreover, rising awareness regarding chronic diseases among the patient population and improving healthcare access for treatment will further escalate business growth in the Asia Pacific region. According to the WHO, in India, cardiovascular diseases are the leading cause of death in both females and males. The increasing patient pool will enhance the market demand over 2020 to 2026.
 

Adoption of strategic initiatives to strengthen market position will upsurge growth opportunities

Prominent players operating in the blood gas and electrolyte analyzers market share are Abbott, Convergent Technologies, Dalko Diagnostics, Edan Instruments, Siemens, and Roche among others. These market players are majorly focusing on various strategies including merger, collaboration, acquisitions and partnerships. These strategies are adopted to strengthen their market position and sustain market competition as well as to enhance the product portfolio.
 

Some of the recent industry developments:

• In May 2018, OPTI Medical announced the launch of E-Lyte CCA cassette, for use on the TS2 Blood Gas and Electrolyte Analyzers as well as OPTI CCA-TS. The new product launch enabled company to expand its blood gas and electrolyte analyzers product portfolio and strengthen business revenue.
   
• In July 2017, Siemens announced the acquisition of Epocal Inc. This acquisition helped the organization to expand its blood gas portfolio in point-of-care segment.
   

The blood gas and electrolyte analyzers industry research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:
 

By Modality

• Bench top
• Portable

By Product

• Blood gas analyzers
• Electrolyte analyzers
• Combined analyzers
• Consumables

By End-use

• Central laboratories
• Point-of-care
• Diagnostic centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia